458 related articles for article (PubMed ID: 29565447)
21. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Kim D
Neoplasia; 2019 Feb; 21(2):206-215. PubMed ID: 30622051
[TBL] [Abstract][Full Text] [Related]
22. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
23. IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma.
Hu Z; Sui Q; Jin X; Shan G; Huang Y; Yi Y; Zeng D; Zhao M; Zhan C; Wang Q; Lin Z; Lu T; Chen Z
J Exp Clin Cancer Res; 2024 Feb; 43(1):63. PubMed ID: 38424624
[TBL] [Abstract][Full Text] [Related]
24. SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
Colomiere M; Findlay J; Ackland L; Ahmed N
Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
[TBL] [Abstract][Full Text] [Related]
26. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling.
Yan H; Guo BY; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 470(4):947-54. PubMed ID: 26826383
[TBL] [Abstract][Full Text] [Related]
28. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
29. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
[TBL] [Abstract][Full Text] [Related]
30. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
31. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract][Full Text] [Related]
32. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
33. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.
Fu LX; Lian QW; Pan JD; Xu ZL; Zhou TM; Ye B
J Biol Regul Homeost Agents; 2017; 31(1):51-58. PubMed ID: 28337870
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression.
Xu L; Deng Q; Pan Y; Peng M; Wang X; Song L; Xiao M; Wang Z
Int J Mol Med; 2014 Jan; 33(1):91-6. PubMed ID: 24212330
[TBL] [Abstract][Full Text] [Related]
35. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
36. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.
Zhou B; Sun C; Li N; Shan W; Lu H; Guo L; Guo E; Xia M; Weng D; Meng L; Hu J; Ma D; Chen G
Int J Oncol; 2016 May; 48(5):2087-97. PubMed ID: 26983899
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis.
Zhang F; Cui JY; Gao HF; Yu H; Gao FF; Chen JL; Chen L
Future Oncol; 2020 Nov; 16(32):2619-2633. PubMed ID: 32804554
[No Abstract] [Full Text] [Related]
39. Cancer-associated Fibroblasts induce epithelial-mesenchymal transition
Jia C; Wang G; Wang T; Fu B; Zhang Y; Huang L; Deng Y; Chen G; Wu X; Chen J; Pan Y; Tai Y; Liang J; Li X; Hu K; Xie B; Li S; Yang Y; Chen G; Zhang Q; Liu W
Int J Biol Sci; 2020; 16(14):2542-2558. PubMed ID: 32792856
[TBL] [Abstract][Full Text] [Related]
40. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV
Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
